Linda Palczuk
Director/Board Member presso AVADEL PHARMACEUTICALS PLC
Patrimonio netto: 885 036 $ in data 31/03/2024
Profilo
Linda S.
Palczuk is an Independent Director at Avadel Pharmaceuticals Plc and the Chief Operating Officer at Envara Health, Inc. She was previously the President & Chief Executive Officer at Osiris Therapeutics, Inc., Vice President-Sales & Marketing at AstraZeneca Pharmaceuticals LP, and Chief Operating Officer at Verrica Pharmaceuticals, Inc. Palczuk holds an undergraduate degree from Franklin & Marshall College and an MBA from Alfred Lerner College of Business & Economics.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/09/2023 | 52 400 ( 0.03% ) | 885 036 $ | 31/03/2024 |
Posizioni attive di Linda Palczuk
Società | Posizione | Inizio |
---|---|---|
AVADEL PHARMACEUTICALS PLC | Director/Board Member | 01/07/2018 |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Chief Operating Officer | 01/01/2019 |
Precedenti posizioni note di Linda Palczuk
Società | Posizione | Fine |
---|---|---|
VERRICA PHARMACEUTICALS INC. | Chief Operating Officer | 22/04/2019 |
OSIRIS THERAPEUTICS, INC. | Chief Executive Officer | 09/02/2018 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Sales & Marketing | 01/03/2015 |
Formazione di Linda Palczuk
Franklin & Marshall College | Undergraduate Degree |
Alfred Lerner College of Business & Economics | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
Aziende private | 3 |
---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Health Technology |
- Borsa valori
- Insiders
- Linda Palczuk